Neuro Rehab VR

Neuro Rehab VR operates at the intersection of digital therapeutics, rehabilitation hardware, and clinical workflow software. Its Smart Therapy™ Complete Solution combines a wireless PICO XR headset, gamified activities, clinician-controlled sessions, movement tracking, real-time analytics, and AI-assisted SOAP-note documentation. That combination differentiates the company from conventional therapy software focused primarily on exercise libraries or documentation, while its wireless setup and reported deployment time of under 30 seconds target operational friction in hospitals and outpatient clinics. The company also offers a Foundational Virtual Reality Therapy Certification, giving it an education and implementation layer beyond the device itself. Its stated use across more than 100 hospitals and outpatient clinics, including VA medical centers, suggests a B2B healthcare focus rather than a direct-to-consumer model. However, the available profile does not identify verified named competitors, making precise benchmarking against companies such as other XR rehabilitation vendors inappropriate. Relative to traditional clinic-based rehabilitation, Neuro Rehab VR’s differentiators are immersive engagement, session-level analytics, and documentation automation.

Neuro Rehab VR’s trajectory shows a progression from research-backed product development to institutional deployment. The company was founded in March 2018 by Veena Somareddy and Bruce Conti, received a $224,893 grant in February 2019, and raised a $1.6 million seed round on Oct 4, 2021. Those two rounds bring total reported funding to $1,824,893 and establish a foundation for developing VR and AR therapy products around neuroplasticity. The more recent inflection point is commercial adoption: Smart Therapy™ deployments were announced at Ignite Medical Resorts in Norman on Apr 9, 2026, a partnership with Spartanburg Regional was announced on Apr 22, 2026, and a Texas NeuroRehab Center collaboration followed on Jun 1, 2026. The product’s expansion from therapy activities into AI-generated SOAP notes, clinician controls, analytics, and certification broadens its value proposition from hardware-enabled treatment to workflow support and staff enablement. Future scale will depend on converting deployments into repeatable health-system contracts and demonstrating measurable clinical and administrative outcomes.